eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Randomized, phase II, double-blind, placebo-controlled trial of conventional chemoradiation and adjuvant temozolomide plus cediranib versus conventional chemoradiation and adjuvant temozolomide plus placebo in patients with newly diagnosed glioblastoma

eagle-i ID


Resource Type

  1. Clinical trial


  1. ClinicalTrials.gov url
  2. Intervention
    Cediranib maleate
  3. Intervention
  4. Intervention
    Radiation therapy
  5. Intervention
  6. Additional Topic(s)
    Antineoplastic combined chemotherapy protocols
  7. Resource Description
    PURPOSE: This randomized phase II trial is studying temozolomide, radiation therapy, and cediranib maleate to see how well they work compared with temozolomide, radiation therapy, and a placebo in treating patients with newly diagnosed glioblastoma.
  8. Contact
    Berenberg, Jeffrey
  9. PI
    Berenberg, Jeffrey
  10. Topic
    brain cancer
  11. Study Population
    Males and females age 18 and older with histologically confirmed glioblastoma or gliosarcoma (WHO grade IV).
  12. Website(s)
  13. Funded by
    Radiation Therapy Oncology Group
  14. Phase
    Phase 2 clinical trial
  15. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016